Matthew Henriksson analyst

Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).

Matthew Henriksson

Work Performance Price Targets & Ratings Chart

Analyst Matthew Henriksson, has had 100% of price targets met with an average potential upside of 17.02%, reached in 400 days on average. Previously, Matthew Henriksson worked at CITI.

Matthew Henriksson has documented 8 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.

Wall Street Analyst Matthew Henriksson

Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) on 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%), with a performance score of 1.67.

Average potential price target upside

GMED Globus Medical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2025

$90

$23.11 (34.55%)

$100

13 days ago
(09-Nov-2026)

34/38 (89.47%)

$13.63 (17.85%)

357

Buy Since 17-Dec-2025

$105

$38.11 (56.97%)

$112

16 days ago
(06-Nov-2026)

0/3 (0%)

$33.95 (47.78%)

Buy Since 06-Nov-2024

$78

$11.11 (16.61%)

$104

16 days ago
(06-Nov-2026)

14/16 (87.5%)

$6.95 (9.78%)

264

Buy Since 06-Apr-2020

$100

$33.11 (49.50%)

$99

16 days ago
(06-Nov-2026)

9/13 (69.23%)

$28.95 (40.75%)

210

Buy Since 25-Feb-2026

$100

$33.11 (49.50%)

$117

16 days ago
(06-Nov-2026)

3/7 (42.86%)

$28.95 (40.75%)

499

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?